Oxford University to test COVID-19 vaccine response among children for the first time

In a first, University of Oxford has launched a study to assess safety and immune response of its COVID-19 vaccine in children. study would test efficacy of vaccine that it developed along with AstraZeneca Inc., on children between ages six to 17 years. As of now, Oxford shot has been granted approval in various nations including UK, Argentina, Dominican Republic, El Salvor, Mexico and Morocco amongst ors.

According to Sky News, Oxford researchers will use 300 volunteers to assess wher  coronavirus vaccine will produce a strong immune response in children. trials are set to begin later this month at Oxford University and its partner sites in London, Southampton and Bristol. For purpose of study, researchers will give vaccine shots to 240 children with rest of m being given a control meningitis jab.

Professor Andrew Pollard, chief investigator on Oxford vaccine trial, Speaking to Sky News, stressed that although re was less chance of young kids getting affected by COVID-19, it was crucial to establish safety and immune response to vaccine in children as some may benefit from vaccination. Since initial report, virus has hammered United Kingdom with caselo of infection surging to 4,013,799 and 116,287 fatalities. 

Re: COVID-19 Jab Against Variant To Be Prepared By Autumn, Profits Doubled: Oxford-AstraZeneca

Re:Covid-19: WHO Supports Use Of Oxford Vaccine 'even Against Variants'

WHO support Oxford shots 

Earlier this week, World Health Organization (WHO) recommended using vaccine developed by University of Oxford and AstraZeneca, even for countries who are battling new variants of coronavirus. organisation furr said that vaccine could be used in people aged over 65. Seen as ‘vaccine of world’, vaccine is cheap and can be mass produced and stored in a standard fridge. 

This comes in response to a report that alleged that AstraZeneca vaccines were less effective against mutant of coronavirus first detected in South Africa. WHO Strategic visory Group of Experts on Immunization (SAGE) has found out that vaccine is effective against South African variant. 

Re:Oxford/AstraZeneca Jab Shows 'reduced Efficacy Against African Variant Of Coronavirus'

Re: Oxford To Run Trial Alternating Doses Of COVID-19 Vaccines In UK, First Of Its Kind

Image: AP